RxDoctor Payments Data

Daniel Simon, MD

Urology · Riverton, UTNPI 1942720586

Payments from drug & device makers

What this record shows

This record is dominated by grants: $30,000 of the $32,982 with a category attached, or 91.0%. Boston Scientific accounts for 92.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $30,320 and has fallen 99.2% since, to $228 in 2025. Among urology clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,982in general payments, 2019–2025

Across 31 payments — averaging $1063.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$30K
  • Intuitive Surgical$2K
  • Axonics, Inc.$362
  • Ambu Inc.$152
  • Astellas Pharma US Inc$94
  • Valencia Technologies Corporation$87
  • plus $221 from 6 others

What the payments were for

  • Grants$30,00091%
  • Food & beverage$1,3724%
  • Education$1,6095%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,982 in reported general payments places this provider in the 90th percentile of 96 urology providers in Utah.

See all urology providers in Utah

Medicare billing

Part B allowed, 2024
$64,957
Medicare patients
117
Services billed
1,677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl94$1,131
Oxybutynin Chloride ErOxybutynin Chloride41$604
Oxybutynin Chloride20$345
Finasteride23$303
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen34$149
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim22$118

Paid to pharmacies, not to this prescriber.

Other urology in Riverton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →